Fingerprint
Dive into the research topics of 'Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically